Effects of Acute Exercise and Allopurinol Administration on Soluble Urokinase Plasminogen Activator Receptor (suPAR)

被引:11
|
作者
Sanchis-Gomar, Fabian [1 ]
Bonaguri, Chiara [2 ]
Pareja-Galeano, Helios [1 ]
Carmen Gomez-Cabrera, Mari [1 ]
Candel, Jorge [3 ]
Vina, Jose [1 ]
Lippi, Giuseppe [2 ]
机构
[1] Univ Valencia, Fdn Invest Hosp Clin Univ, Fac Med, Dept Physiol,INCLIVA, Valencia 46010, Spain
[2] Univ Parma, Azienda Osped, UO Diagnost Ematochim, Dipartimento Patol & Med Lab, I-43100 Parma, Italy
[3] Valencia CF Med Serv, Valencia, Spain
关键词
physical exercise; soluble urokinase plasminogen activator receptor; suPAR; allopurinol; EXHAUSTIVE PHYSICAL-EXERCISE; MORTALITY; TOUR;
D O I
10.7754/Clin.Lab.2012.120728
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Although physical exercise acutely increases the most widely used inflammatory biomarkers, there is no information on its effect on soluble urokinase plasminogen activating receptor (suPAR), a circulating biomarker increasingly used for the assessment of systemic inflammation. Methods: suPAR was assessed with the quantitative suPARnostic (R) Standard ELISA Assay (Virogates, Birkerod, Denmark) in 12 professional football players before and after a football match. The athletes were divided into two experimental groups. An oral dose of 300 mg of allopurinol was administered to one group of six participants four hours before a match; the other six participants received placebo. Results: Serum suPAR concentration did not vary significantly after the match in both the placebo and allopurinol group. No significant differences were observed between placebo and allopurinol groups at baseline and after the game. Conclusions: At variance with other consolidated inflammatory biomarkers, suPAR is not influenced by either physical exercise or administration of xanthine oxidase inhibitors.
引用
收藏
页码:207 / 210
页数:4
相关论文
共 50 条
  • [1] Soluble urokinase plasminogen activator receptor (suPAR) promotes atherosclerosis
    Drueke, Tilman B.
    Massy, Ziad A.
    KIDNEY INTERNATIONAL, 2023, 103 (03) : 451 - 454
  • [2] Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis
    Garnaes, Emilie
    Mortensen, Christian
    Hobolth, Lise
    Andersen, Ove
    Nehlin, Jan
    Moller, Soren
    PLOS ONE, 2019, 14 (08):
  • [3] Soluble urokinase type plasminogen activator receptor (suPAR) and mortality in acute pulmonary embolism
    Oblitas, Crhistian-Mario
    Lopez-Rubio, Marina
    Lago-Rodriguez, Marta-Olimpia
    Galeano-Valle, Francisco
    Garcia-Gamiz, Mercedes
    Zamora-Trillo, Angielys
    Walther, Luis-Antonio Alvarez-Sala
    Demelo-Rodriguez, Pablo
    MEDICINA CLINICA, 2024, 163 (06): : 281 - 285
  • [4] The role of soluble urokinase plasminogen activator receptor (SuPAR) as an indicator of the severity of acute pancreatitis
    Kucukceran, Kadir
    Ergin, Mehmet
    Kilinc, Ibrahim
    Karaibrahimoglu, Adnan
    Colak, Tamer
    Tuncar, Alpay
    Dundar, Zerrin Defne
    Kocak, Sedat
    Girisgin, Abdullah Sadik
    Gul, Mehmet
    Cander, Basar
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2018, 48 (06) : 1175 - 1181
  • [5] The levels of soluble urokinase plasminogen activator receptor (suPAR) in saliva are influenced by acute stress
    Fernandez-Botran, Rafael
    Szabo, Yvette Z.
    Lyle, Keith B.
    Newton, Tamara L.
    BIOLOGICAL PSYCHOLOGY, 2021, 165
  • [6] Soluble urokinase plasminogen activator receptor (suPAR) in children with nephrotic syndrome
    Malina, Michal
    Zieg, Jakub
    Rosik, Tomas
    Simankova, Nada
    Vondrak, Karel
    Dusek, Jiri
    Seeman, Tomas
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1591 - 1591
  • [7] SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) LEVELS IN PREGNANCY AND PREECLAMPSIA
    Beko, G.
    Biro, E.
    Toldi, G.
    Stenczer, B.
    Molvarec, A.
    Rigo, J.
    Vasarhelyi, B.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S693 - S693
  • [8] SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) AS A PREDICTOR OF CARDIAC ISCHEMIA
    Feroze, Rafey
    Anderson, Elizabeth
    Hawes, Armani
    Launius, Christopher
    Blakely, Penelope
    Murthy, Venkatesh
    Hayek, Salim
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 206 - 206
  • [9] Urokinase plasminogen activator (uPA) and soluble urokinase plasminogen activator receptor (suPAR) serum level in patients with malignant lymphomas
    Hus, I
    Cioch, M
    Jawniak, D
    Manko, J
    Dmoszynska, A
    Chrapko, M
    Hus, M
    BULLETIN OF THE VETERINARY INSTITUTE IN PULAWY, 2002, : 141 - 144
  • [10] Auto-activation of plasminogen in the presence of soluble urokinase plasminogen activator receptor (suPAR).
    An, SSA
    Ngo, E
    Greenfield, RS
    BLOOD, 2000, 96 (11) : 71B - 71B